IMMUNICH
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNICH Trademark

Serial Number: 76230157 • Registration: 2807717

IMMUNICH is a trademark filed by CONNEX Gesellschaft zur Optimierung von Forschung und Entwicklung mbH on March 23, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CONNEX Gesellschaft zur Optimierung von Forschung und Entwicklung mbH

Am Klopferspitz 19
Martinsried 82152 , DE

Entity Type: 03

Trademark Details

Filing Date

March 23, 2001

Registration Date

January 27, 2004

Published for Opposition

November 4, 2003

Cancellation Date

September 3, 2010

Goods & Services

Chemical, biochemical, and biological products for performing analytical studies in clinical settings, namely, diagnostic reagents for diagnosis of excreta; pharmaceutical and veterinary products and preparations for health care, namely, diagnostic agents, reagents and reagent mixtures for use in the clinical medical and veterinary fields; diagnostic agents, reagents, and reagent mixtures for the clinical diagnosis of diseases, namely, infectious diseases, system diseases, and auto-aggressive diseases in humans and animals, namely, for examining bodily fluids and respiratory condensate; therapeutic agents containing proteins; polypeptide or peptides, monoclonal or polygonal antibodies for clinical medical use; expression systems, namely, systems consisting of procaryotic or enearyotic expression cells and expression vectors for clinical use; cellular assays for clinical medical use; clinical medical test kits comprised primarily of reaction vessels, namely coated reaction microtitration plates and reaction tubes, reagents, reagent mixtures, substrates, buffer substances, and solutions for performing analyses, namely, buffer solutions, control solutions, substrate solutions, and stopping reagents

chemical products for industrial and scientific research purposes, namely, reagent test strips, test reagents, and scientific research aerosols, for performing analytical reactions for the purpose of environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis, for use in the research and development of medical and veterinary medicine; test reagents for analytical studies of human and animal samples, namely, blood, urine, stool and other body fluids and aerosols, for the analysis of agricultural products, for environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis; diagnostic reagents, reagent mixtures, substrates, buffer substances and solutions for scientific research, namely, buffer solutions, control solutions, substrate solutions, and stopping reagents appropriate for such analyses; chemical, biochemical and biological products for performing analytical studies in scientific research, namely diagnostic reagents for the diagnosis of excreta; cellular assays for scientific research use; scientific research test kits comprised primarily of reaction vessels namely, coated reaction microtitration plates and reaction tubes, reagents, reagent mixtures, substrates, and buffer substances

devices and test components for analytical studies of human and animal samples of blood, urine, stool and other body fluids; receptacles and devices for collecting human bodily fluid samples, namely, blood drawing apparatus and urine flasks; apparatus for the production of antibodies; apparatus for receiving expression systems; apparatus for collecting human bodily fluid samples for medical, scientific and veterinary purposes

scientific and industrial research; medical laboratory services, development of new technology for others in the field of cell culture, monoclonal antibodies, peptides, polypeptides and proteins, genetic expression systems, cellular assays, and production of chemical compounds; product research and development performed under contact for the benefit of others; development and implementation of diagnostic and analytical procedures for others in the field of environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis, diagnosis of infectious diseases, system diseases and auto-aggressive diseases in humans and animals; development of therapeutic compositions for others in the field of curing diseases of humans and animals, namely compositions on an immunological basis for curing diseases; research and development for others of biological systems, namely, genetic expression systems, cellular assays and animal cellular models

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 3, 2010 C8..
REVIEW OF CORRESPONDENCE COMPLETE
Sep 16, 2006 CORV
REVIEW OF CORRESPONDENCE COMPLETE
Aug 12, 2006 CORV
PAPER RECEIVED
Oct 7, 2004 MAIL
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2004 R.PR
PUBLISHED FOR OPPOSITION
Nov 4, 2003 PUBO
NOTICE OF PUBLICATION
Oct 15, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2003 CNSA
CASE FILE IN TICRS
Jul 23, 2003 CFIT
PAPER RECEIVED
Jul 14, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2003 CRFA
FINAL REFUSAL MAILED
Apr 30, 2003 CNFR
Sec. 1(B) CLAIM DELETED
Mar 28, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2003 CRFA
PAPER RECEIVED
Mar 28, 2003 MAIL
ASSIGNED TO EXAMINER
Jan 3, 2003 DOCK
INQUIRY AS TO SUSPENSION MAILED
Sep 26, 2002 CNSI
LETTER OF SUSPENSION MAILED
Mar 12, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2002 CRFA
NON-FINAL ACTION MAILED
Jul 17, 2001 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2001 DOCK